RTsafe

📍 Athens, Greece🗓 Founded 2014👥 19 employees💰 Last funded Jun 2018
RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. Our Vision Helping to create a world where every radiotherapy intervention is tested on a personalized phantom before the real patient, thus enhancing safety and effectiveness of treatment. We combine proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms for end‐to‐end commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate models enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology industry to fine‐tune its products. The result is more effective individualized therapy and reduced patient risk. 
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in RTsafe?
RTsafe has 1 investors on record on gritt.io, 1 mid-stage.
When did RTsafe last raise funding?
The most recent investment in RTsafe recorded on gritt.io was in June 2018.
When was RTsafe founded?
RTsafe was founded in 2014.
What industry is RTsafe in?
RTsafe operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is RTsafe based?
RTsafe is headquartered in Athens, Greece.